On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Friendable Inc. (FDBL) Fan Pass Platform Signs Remy Boy Monty

  • FDBL announces new artist acquisition: Remy Boy Monty
  • Fan Pass capable of satisfying fans’ overwhelming appetite for content while providing new revenue streams for Monty
  • Monty opens up potential for signing additional artists
With the focus of connecting and engaging users, the mobile tech and marketing company Friendable (OTC: FDBL) launched its platform Fan Pass Live in July 2020. In November, the company announced a new artist acquisition: Remy Boy Monty (https://ibn.fm/odUSn). The live-streaming platform Fan Pass is FDBL’s flagship offering designed to help artists engage with their fans around the world and earn revenue from live-streaming performances, merchandise sales and fan subscriptions. The Fan Pass platform supports artists at all levels, creating exclusive artist channels based on their particular music genre. When in-person performances re-emerge, Friendable intends to allow fans exclusive access to VIP, Meet & Greet, and Backstage experiences as well. Today fans across the world have an overwhelming appetite for content; this platform can satiate that need. Montana “Monty” Bucks, aka Remy Boy Monty, was introduced to FDBL’s Fan Pass platform before the launch, but the timing was not right. Now it is, and Monty is ready to grow and engage his fans while creating new revenue streams worldwide through Fan Pass. “Having met the Remy Boy team prior to our launch, I was hopeful of the opportunity to bring him onto the Fan Pass platform, and now that time has come only a few short months later,” said Friendable CEO Robert A. Rositano Jr. “Myself, our management team and Fan Pass agents in general are excited to have Remy Boy on our platform, and his channel is being built for release just as soon as we receive graphic sign-off and the proper approvals regarding the look of his artist channel.” Remy Boy Monty and his childhood friend Willie “Fetty Wap” Maxwell, co-founded the rap troupe Remy Boyz 1738. Monty is now CEO of the company and its record imprint. Artists on the imprint include Fetty Wap and Chaos and Tap. Remy Boyz has a large following with approximately 435,000 Instagram followers, 1,827 monthly Spotify listeners and more than 23,000 YouTube subscribers. Monty officially launched his first solo album in June 2015, selling more than 1 million domestic copies, with one single from the album reaching No. 2 on the U.S. Rap Songs Chart. In it’s first six months, the single’s video gained 100 million views on YouTube. Monty has appeared on “The Tonight Show Starring Jimmy Fallon” and toured with Fetty Wap and opener Post Malone on the “Welcome to the Zoo” tour. Monty and Wap have a collaborative track, “My Way,” which was nominated at the BET Hip Hop Awards for Best Collaboration, Duo or Group in 2015. The album reached No. 1 on the U.S. Billboard 200, No. 2 on the U.K. R&B Albums, and surpassed No. 15 in Australia, Canada and Sweden. Monty’s addition to Fan Pass opens up more artist possibilities. The Remy Boyz have been highly successful, and as Fan Pass continues to grow, FDBL looks forward to the potential of bringing more of them to the platform. “It’s amazing to have an artist like Remy Boy,” said Rositano, “who just happens to have started out with another artist we have had the pleasure of working with in the past on another project (Fetty Wap), whom we hope to see on Fan Pass in the near future as well.” The Fan Pass Platform was launched as a solution for artists looking to increase revenue streams during the COVID-19 pandemic and associated shutdowns. For more information, visit the company’s website at www.Friendable.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.